Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$3.7 - $4.75 $161,197 - $206,943
-43,567 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$4.05 - $6.1 $10,870 - $16,372
-2,684 Reduced 5.8%
43,567 $183,000
Q4 2017

Feb 14, 2018

SELL
$2.8 - $5.55 $677 - $1,343
-242 Reduced 0.52%
46,251 $257,000
Q3 2017

Nov 13, 2017

BUY
$3.2 - $20.8 $148,777 - $967,054
46,493
46,493 $151,000

About OTONOMY, INC.


  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.